StockData
Amneal Pharmaceuticals, Inc. logo

Amneal Pharmaceuticals, Inc. (AMRX) stock

AMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3062% above fair value
$21.23−0.15 (-0.70%)

Close on Nov 16, 2026Market cap $6.78BP/E 43.3Yield –

Amneal Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Amneal Pharmaceuticals's price to sales ratio was 2.3× on Nov 11, 2026, against 1.4× a year earlier. Over the last 5 years it ranged from 0.1× to 2.3×, with a median of 0.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.3×+0.9
2025Dec 31, 20251.4×+0.5
2024Dec 31, 20240.9×+0.5
2023Dec 29, 20230.4×+0.3
2022Dec 30, 20220.1×−0.2
2021Dec 31, 20210.3×−0.0
2020Dec 31, 20200.4×−0.0
2019Dec 31, 20190.4×−0.2
2018Dec 31, 20180.6×–

More Amneal Pharmaceuticals figures

See a number that looks wrong?